|
- Products - Vital Statistics Rapid Release - Provisional Drug Overdose Data
Provisional Drug Overdose Death Counts Delays in reporting: The Monthly Provisional Drug Overdose Death Counts report provides estimates for the United States and jurisdictions within 4 months after the date of death Some states currently have longer than usual delays in reporting drug overdose deaths Recent trends may underestimate the death count in affected states and this potential
- Coronavirus Disease 2019 (COVID-19) Vaccine Safety
Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by the SARS-CoV-2 virus You can protect against severe COVID-19 disease with vaccination CDC continuously monitors the safety of COVID-19 vaccines using several different safety systems
- Tetanus Vaccine Recommendations | Tetanus | CDC
CDC recommends tetanus vaccines for people across the lifespan, including for wound management Follow the recommended immunization schedule to ensure that your patients get the tetanus vaccines that they need Follow CDC's immunization schedule to ensure that your patients are protected from tetanus
- Centers for Disease Control and Prevention | CDC
To make science and data easier for broad audiences to interpret, CDC is translating science into practical, easy to understand policy by clarifying and presenting scientific language so that anyone can understand it and standardizing guideline development across the agency
- Infection Control Guidance: SARS-CoV-2 | COVID-19 | CDC
See infection prevention and control (IPC) guidance and practices for healthcare personnel
- E-Cigarette Use Among Youth | Smoking and Tobacco Use | CDC
E-cigarettes are the most commonly used tobacco product among U S youth No tobacco products, including e-cigarettes, are safe, especially for children, teens, and young adults Learn more about e-cigarette use among youth
- OSHA Respirator Requirements for Selected Chemicals | NIOSH | CDC
Revisions to the OSHA Respiratory Protection Standard (29 CFR 1910 134) became effective on April 8, 1998 Incorporated within the preamble of this ruling were changes to OSHA regulations for several chemicals or substances, which are listed as subheadings in blue text throughout this appendix
- About Hantavirus | Hantavirus | CDC
Signs and symptoms Hantavirus Pulmonary Syndrome (HPS) HPS is a severe and potentially deadly disease that affects the lungs Symptoms of HPS usually start to show 1 to 8 weeks after contact with an infected rodent Early symptoms can include: fatigue fever muscle aches, especially in the large muscle groups like the thighs, hips, back, and sometimes shoulders About half of all HPS patients
|
|
|